instruction:
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
question:
Diana Nyad cries as she speaks to reporters and fans after arriving back in Key West, Florida August 9, 2011. An asthma attack, a painful shoulder and battering wind and waves forced 61-year-old swimmer Diana Nyad to abandon early on Tuesday her bid to become the first person to swim from Cuba to Florida without a shark cage. REUTERS/Rob O'Neal/Florida Keys News Bureau/Handout The American, who tried and failed the 103-mile swim more than three decades ago when she was 28, gave up after enduring nearly 30 hours of a crossing expected to last 60, exhausted by her body’s limits and the force of the elements. “I thought this was my time. We set out, thinking the conditions were favorable. They were not. The winds were stronger and the waves were bigger than what I’d expected,” she told Reuters after her escort boat Bellisimo brought her to the Key West Yacht Club on Stock Island. Nyad, a veteran long-distance swimmer, had started out strongly, stroking rhythmically through calm seas after she dived off from the Marina Hemingway on the western outskirts of Cuba’s capital Havana at 7:45 p.m. EDT on Sunday. But, she said in an interview with CNN, she suffered an unexpected bout of asthma that left her gasping for oxygen. An “excruciating pain” also developed in her right shoulder and these physical handicaps combined with contrary winds and seas that pushed her floundering off course. “Last night at midnight, I was trembling, the 11 hours of asthma had taken so much from my body ... I just knew that it wasn’t mind over matter any more, I was absolutely spent,” Nyad, wearing a white bathrobe, told CNN at Stock Island. She said that toward the end she was “limping” and “slapping around” in the water and even resorted to breast stroke instead of her usual crawl. Her doctor joined her in the water at one point to try to give her relief with an inhaler. CNN, which had a producer on one of the boats accompanying Nyad, said she was vomiting when she was brought aboard an escort boat at 12:45 a.m. EDT (0445 GMT) on Tuesday. Nyad, who later recovered to breakfast on scrambled eggs on her way to Key West, was disappointed but had no regrets about her motives for attempting the swim. She turns 62 this month. She had said her main aim in attempting the Cuba to Florida swim again, without a shark cage, was to help people her age and older realize they can still achieve many things. “I was the best person I could be ... that’s the message. I dug down, I dug deep ... Whatever you’re doing, do your job well,” Nyad, who has the muscled body and the steely resolve of a marathon swimmer, told CNN. Raised in southern Florida, she first tried the crossing from Cuba in 1978, but failed in the face of winds and heavy waves. The same swim was completed successfully in May 1997 by Australian Susan Maroney, who was 22 at the time. But Maroney used a shark cage. Nyad’s flotilla of escort vessels included specially equipped kayaks transmitting an anti-shark shield in the form of an electronic signal that is annoying to the sleek ocean predators that stalk the waters of the Florida Straits. When she was years younger, Nyad put herself into the record books by swimming around Manhattan in 1975 in less than eight hours and by completing a 102.5 mile swim from Bimini in the Bahamas to Florida in 1979. Despite her having to abandon her bid, her fans tweeted their admiration on Tuesday. “That was Diana’s whole point. Rethink old. Sorry she (had) to abandon but my admiration doesn’t waiver. Go Diana,” said one. Asked whether she would attempt the swim again, Nyad told CNN: “You don’t beat Mother Nature ... I think I’m going to have to go to my grave without swimming from Cuba to Florida.”
answer:
Sea defeats body, not spirit, of swimmer, 61.


question:
The story mentioned that the cost of this drug treatment was several thousand dollars a month and that this was higher than the costs of other treatments. It would have been better to provide a more concrete estimate of costs (several thousand – does this mean 2,3 or 6 thousand?). The story might have included some information about additional costs that would be encountered with the comparison treatment such as the cost of intraveneous infusions, testing to  evaluate side-effects, and other connected costs. The story did a good job reporting the data comparing patient survival with Iressa as compared to individuals treated with IV chemotherapy. The story skimmed over the side effects; reducing the frequency of bothersome or life threatening side effects would seem to be an advantage. The story mentioned quality of life factors that appear to be better with Iressa but did not  quantify the benefit observed. Borderline satisfactory. The story listed the common side effects of the treatment though it failed to indicate the frequency with which these were seen. In addition, rather than than merely listing these, the story could have included some information about the severity of the side effects (i.e. bothersome vs. fatal). The story provided information about the size of the study conducted, the nature of the patients that were enrolled, and that the drug company that markets the drug funded the study. The study was designed as a non-inferiority survival trial to compare this medication with docotaxel, a chemotherapy treatment often used in individuals who have lung cancer and have had platinum based treatment but who are experiencing a return of their cancer. (While the story did provide information about the survival outcomes, it also included information comparing side effects.) The story ended with a comment from one of the interviewed clinicians about quality of life being better with Iressa. The story should have been clearer about the predetermined endpoint of the study (longevity) and should not have ended with less data driven information. The story did not engage in overt disease mongering. However the headline does not hint that the trial is not about first-line cancer treatment, rather just patients who have been treated previously with a platinum-based chemotherapy. The story included quotes from two individuals identified as not being connected with the study reported upon but with relevant expertise. The story provided information about two treatment options for individuals who have recurrence of a previously treated lung cancer. It did not provide information about the natural history of not undergoing additional treatment for this condition which is necessary for evaluating the relative merit of the two treatments discussed. The story did not mention radiation and surgery which are both options for some limited cancers. The story mentions that the medication Iressa (gefitinib) is sold in the United States but that its availability in Europe is limited. The story presented the use of Iressa as a treatment of individuals with lung cancer who had previously been treated with a platinum-based regimen as though it was a novel application. However – this drug was approved by the FDA in 2003 for this purpose. While the results of study reported on are interesting, the story did not provide the reader with a realistic picture of about the novelty of this product. Does not appear to rely on a press release.
answer:
Pill as good as chemo on lung cancer, but costlier


question:
The story quotes an expert who states that exercise is ‘cheap’, which is generally true, but can vary depending on the type of exercise. The exercises included in most of the studies examined were taught and supervised by trained individuals, which can increase the cost. The story does not provide any data (either relative or absolute) about the benefits of exercise and other approaches to managing these injuries. This was probably appropriate, because outcomes are defined in different ways depending on the study, but the story author might have explained it. We’ll give the story the benefit of the doubt and grade it satisfactory. The potential harms of exercise in the context of repetitive strain injuries, such as making the injury worse, are not mentioned. The story accurately describes the original article as a review of studies, but it misstates the authors’ conclusions and makes it appear that exercise was far more effective than ergonomic approaches. In the original review, 8 of 14 studies looked at the effects of exercise compared with no treatment, and the authors state that here they found conflicting evidence of the effectiveness of exercise. The story inaccurately states that ‘the majority found positive results.’ Although the authors reported that the evidence for ergonomic adjustments such as special keyboards was also conflicting, the story says that evidence of their efficacy was limited. It should also have stated that most of the 22 studies reviewed were rated as poor quality by the reviewers, and that 103 of the 126 references reviewed were rejected for various reasons. The story states that the direct and indirect costs associated with repetitive strain disorders are as much as $100 billion dollars annually in the U.S. The original article actually estimated these costs at about 1/50 that much, or $2 billion. This exaggeration of impact is a form of disease-mongering. Story quotes the lead author of the review as well as other experts, whose affiliations are provided. The article correctly states that many types of exercise have been studied for repetitive strain injuries. However, rather than “hiking, cycling, walking, swimming and yoga,” as stated in the article, the studies examined generally were investigating the effects of prescribed exercises in a supervised context. The story mentions that exercise in various forms has been studied as a potential therapy for repetitive strain injuries for many years and is not new. The story does not appear to have relied solely or largely on a news release.
answer:

Exercise may be the Rx for RSI